Serum S-100B protein monitoring in patients with severe traumatic brain injury

@article{Korfias2006SerumSP,
  title={Serum S-100B protein monitoring in patients with severe traumatic brain injury},
  author={Stefanos I Korfias and George Stranjalis and Efstathios J. Boviatsis and Christina Psachoulia and G{\'e}rard Jullien and Barbara Gregson and Alexander David Mendelow and Damianos E. Sakas},
  journal={Intensive Care Medicine},
  year={2006},
  volume={33},
  pages={255-260}
}
S-100B protein is a promising marker of injury severity and outcome after head injury. We examined the relationship between serum S-100B concentrations and injury severity, clinical course, survival, and treatment efficacy after severe traumatic brain injury (TBI). Prospective observational study in a neurosurgical intensive care unit. 102 adult patients with severe TBI, admitted between June 2001 and November 2003 (30 months). Serum S-100B levels were measured by immunoluminometric technique… CONTINUE READING